155 related articles for article (PubMed ID: 29671787)
1. Proteomic Identification of the Galectin-1-Involved Molecular Pathways in Urinary Bladder Urothelial Carcinoma.
Li CF; Shen KH; Chien LH; Huang CH; Wu TF; He HL
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29671787
[TBL] [Abstract][Full Text] [Related]
2. Role of galectin-1 in urinary bladder urothelial carcinoma cell invasion through the JNK pathway.
Shen KH; Li CF; Chien LH; Huang CH; Su CC; Liao AC; Wu TF
Cancer Sci; 2016 Oct; 107(10):1390-1398. PubMed ID: 27440446
[TBL] [Abstract][Full Text] [Related]
3. Clarification of the molecular pathway of Taiwan local pomegranate fruit juice underlying the inhibition of urinary bladder urothelial carcinoma cell by proteomics strategy.
Wu TF; Hsu LT; Tsang BX; Huang LC; Shih WY; Chen LY
BMC Complement Altern Med; 2016 Mar; 16():96. PubMed ID: 26955879
[TBL] [Abstract][Full Text] [Related]
4. Galectin-1 dysregulation independently predicts disease specific survival in bladder urothelial carcinoma.
Wu TF; Li CF; Chien LH; Shen KH; Huang HY; Su CC; Liao AC
J Urol; 2015 Mar; 193(3):1002-8. PubMed ID: 25284818
[TBL] [Abstract][Full Text] [Related]
5. IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder.
Liang PI; Wang YH; Wu TF; Wu WR; Liao AC; Shen KH; Hsing CH; Shiue YL; Huang HY; Hsu HP; Chen LT; Lin CY; Tai C; Wu JY; Li CF
J Clin Pathol; 2013 Jul; 66(7):573-82. PubMed ID: 23539739
[TBL] [Abstract][Full Text] [Related]
6. EMP2 induces cytostasis and apoptosis via the TGFβ/SMAD/SP1 axis and recruitment of P2RX7 in urinary bladder urothelial carcinoma.
Li CF; Chan TC; Pan CT; Vejvisithsakul PP; Lai JC; Chen SY; Hsu YW; Shiao MS; Shiue YL
Cell Oncol (Dordr); 2021 Oct; 44(5):1133-1150. PubMed ID: 34339014
[TBL] [Abstract][Full Text] [Related]
7. Amplification-driven BCL6-suppressed cytostasis is mediated by transrepression of FOXO3 and post-translational modifications of FOXO3 in urinary bladder urothelial carcinoma.
Wu WR; Lin JT; Pan CT; Chan TC; Liu CL; Wu WJ; Sheu JJ; Yeh BW; Huang SK; Jhung JY; Hsiao MS; Li CF; Shiue YL
Theranostics; 2020; 10(2):707-724. PubMed ID: 31903146
[TBL] [Abstract][Full Text] [Related]
8. Loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) is associated with progression of human urothelial carcinomas.
Ohlsson G; Moreira JM; Gromov P; Sauter G; Celis JE
Mol Cell Proteomics; 2005 Apr; 4(4):570-81. PubMed ID: 15734831
[TBL] [Abstract][Full Text] [Related]
9. Targeting MACC1 by RNA interference inhibits proliferation and invasion of bladder urothelial carcinoma in T24 cells.
Xu ST; Ding X; Ni QF; Jin SJ
Int J Clin Exp Pathol; 2015; 8(7):7937-44. PubMed ID: 26339359
[TBL] [Abstract][Full Text] [Related]
10. Inducing cell proliferation inhibition and apoptosis via silencing Dicer, Drosha, and Exportin 5 in urothelial carcinoma of the bladder.
Han Y; Liu Y; Gui Y; Cai Z
J Surg Oncol; 2013 Feb; 107(2):201-5. PubMed ID: 22766726
[TBL] [Abstract][Full Text] [Related]
11. Dual role of TGFBR3 in bladder cancer.
Liu XL; Xiao K; Xue B; Yang D; Lei Z; Shan Y; Zhang HT
Oncol Rep; 2013 Sep; 30(3):1301-8. PubMed ID: 23835618
[TBL] [Abstract][Full Text] [Related]
12. galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas.
Cindolo L; Benvenuto G; Salvatore P; Pero R; Salvatore G; Mirone V; Prezioso D; Altieri V; Bruni CB; Chiariotti L
Int J Cancer; 1999 Feb; 84(1):39-43. PubMed ID: 9988230
[TBL] [Abstract][Full Text] [Related]
13. SH3BGRL3 Protein as a Potential Prognostic Biomarker for Urothelial Carcinoma: A Novel Binding Partner of Epidermal Growth Factor Receptor.
Chiang CY; Pan CC; Chang HY; Lai MD; Tzai TS; Tsai YS; Ling P; Liu HS; Lee BF; Cheng HL; Ho CL; Chen SH; Chow NH
Clin Cancer Res; 2015 Dec; 21(24):5601-11. PubMed ID: 26286913
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal and proteome analysis of a new T24-based cell line model for aggressive bladder cancer.
Makridakis M; Gagos S; Petrolekas A; Roubelakis MG; Bitsika V; Stravodimos K; Pavlakis K; Anagnou NP; Coleman J; Vlahou A
Proteomics; 2009 Jan; 9(2):287-98. PubMed ID: 19105184
[TBL] [Abstract][Full Text] [Related]
15. Galectin-3 expression is associated with bladder cancer progression and clinical outcome.
Canesin G; Gonzalez-Peramato P; Palou J; Urrutia M; Cordón-Cardo C; Sánchez-Carbayo M
Tumour Biol; 2010 Aug; 31(4):277-85. PubMed ID: 20401558
[TBL] [Abstract][Full Text] [Related]
16. Annexin-I overexpression is associated with tumour progression and independently predicts inferior disease-specific and metastasis-free survival in urinary bladder urothelial carcinoma.
Li CF; Shen KH; Huang LC; Huang HY; Wang YH; Wu TF
Pathology; 2010 Jan; 42(1):43-9. PubMed ID: 20025479
[TBL] [Abstract][Full Text] [Related]
17. Expression of bone morphogenetic protein-10 (BMP10) in human urothelial cancer of the bladder and its effects on the aggressiveness of bladder cancer cells in vitro.
Zhang N; Ye L; Wu L; Deng X; Yang Y; Jiang WG
Anticancer Res; 2013 May; 33(5):1917-25. PubMed ID: 23645739
[TBL] [Abstract][Full Text] [Related]
18. Loss of lactate dehydrogenase B subunit expression is correlated with tumour progression and independently predicts inferior disease-specific survival in urinary bladder urothelial carcinoma.
Liao AC; Li CF; Shen KH; Chien LH; Huang HY; Wu TF
Pathology; 2011 Dec; 43(7):707-12. PubMed ID: 22027740
[TBL] [Abstract][Full Text] [Related]
19. Interplay between intergrin-linked kinase and ribonuclease inhibitor affects growth and metastasis of bladder cancer through signaling ILK pathways.
Zhuang X; Lv M; Zhong Z; Zhang L; Jiang R; Chen J
J Exp Clin Cancer Res; 2016 Aug; 35(1):130. PubMed ID: 27576342
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of differentially expressed genes associated with PLK1 in bladder cancer.
Zhang Z; Zhang G; Gao Z; Li S; Li Z; Bi J; Liu X; Li Z; Kong C
BMC Cancer; 2017 Dec; 17(1):861. PubMed ID: 29246203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
